🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🗓️El próximo 14 de octubre a las 16h "Webinar Grupo Parasitología molecular e infecciones emergentes" coordinado por Pedro José Alcolea 🗣️ HERNANDO A DEL PORTILLO  - ISGlobal ✍️ f.mtr.cool/gbbwwmbweh ▶️ Síguelo en directo: f.mtr.cool/xfwubmolgr

Among two U.S prostate cancer registries, the proportion of patients undergoing prostatectomy for indolent cancer dropped over five-fold from 2010 to 2024. ja.ma/3TGuJUa Steven Monda Arnav Srivastava @MUSICurology Todd 〽️ Morgan, MD

Most viewed this week from JAMA Oncology: Total neoadjuvant therapy (TNT) for stage II/III rectal cancer, despite variations in regimen choice, showed efficacy outcomes in routine clinical practice consistent with clinical trials. ja.ma/3TMQ4eI

🗓️Have a look to the upcoming Flow Cytometry workshops at CIPF ⤵️ 🔗cipf.es/education-trai… #FlowCytometry #CIPF

Senescence in cancer dlvr.it/TM2Fjh

A unified pan-cancer proteome atlas dlvr.it/TM2Vvh

#OvarianCancer: A Review jamanetwork.com/journals/jama/…

A must read ⁦EACR⁩ magazine.eacr.org/highlights-in-…

Novel Therapeutic Strategies for Metastatic Prostate Cancer Care sciencedirect.com/science/articl…

Mobility for Extracellular Vesicle Research in Europe (MOVE) youtu.be/_SlxJVi1iUM?si… vía YouTube

A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer in ESMO Open. A new “Risk Stratification”score based on clinical/pathological and radiomics features outperforming conventional methods. esmoopen.com/article/S2059-…

After induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma, radiotherapy plus adjuvant chemotherapy was noninferior to concurrent chemoradiotherapy with reduced severe acute toxicities during radiotherapy. ja.ma/4o4T4ku

La molécula AMPc, una diana terapéutica para recuperar la capacidad locomotora tras una lesión medular upo.es/diario/ciencia…

🔴🟢⚫🔵ASEICA Science Week🔴🟢⚫🔵 🔵Jornada "Ciencia y Cáncer: Mirando al futuro" 📅7 NOV 17:15h 🏛️Bilbao 🗣️Rafa López, Ignacio Duran, Mittelbrunn Lab, Elena Galve, Soraya Casla, Ana Ruiz-Saenz PhD, ArkaitzCarracedoLAB, Marisol Soengas y➕ ✅Acceso libre (registro) aseica.es/jornada-de-div…

La piel es el órgano más extenso de nuestro cuerpo, el que mayor número de mutaciones acumula y el que sufre más incidencia de cáncer. Marisol Quintero -Highlight Therapeutics SL y yo -CNIO Stop Cancer os contamos avances en tratamiento en JELO en Verano Onda Cero share.google/pkhzseObgw2JYw…

📆 En octubre celebraremos la 3ª edición de las Jornadas de Plataformas del Instituto de Salud Carlos III (ISCIII). 👥 Más de 400 expertos participaron en la última edición, organizada por ITEMAS, SCReN - Plataforma de Investigación Clínica ISCIII y Platform ISCIII Biomodels and Biobanks acogida por @IRBLleida 👇 youtube.com/watch?v=bWflhB…

El #ISCIII participa en esta investigación, que aporta novedades relevantes en el estudio del cáncer de mama triple negativo, a través del Área de Oncología de nuestro CIBER ISCIII. ⬇️

🚨 New therapy approved in #sarcoma! EU Medicines Agency has granted the use of 🎯CSFR1 #vimseltinib in patients with #TGCT with funtion deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability ▶️ema.europa.eu/en/medicines/h…

Exciting news! 🧬 Our latest study shows that intermittent fasting improves metabolism, even on a high-fat diet. A step toward personalized nutrition strategies beyond weight loss. 🔬 Read in eBioMedicine. 🔗 thelancet.com/journals/ebiom…

💥Check out our latest work in Nature Communications We identify a new target to impair DNA repair🧬inducing #senescence and #celldeath through synthetic lethality in combination with cancer therapy🧵 🔗Open access PDF: rdcu.be/euQkW